<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased <z:chebi fb="0" ids="29108">Ca2+</z:chebi> influx through activated <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptors and voltage-dependent <z:chebi fb="0" ids="29108">Ca2+</z:chebi> channels (VDCC) is a major determinant of cell injury following <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The activity of these channels is modulated by dynamic changes in the actin cytoskeleton, which may occur, in part, through the actions of the actin filament-severing protein gelsolin </plain></SENT>
<SENT sid="2" pm="."><plain>We show that gelsolin-null neurons have enhanced cell <z:hpo ids='HP_0011420'>death</z:hpo> and rapid, sustained elevation of <z:chebi fb="0" ids="29108">Ca2+</z:chebi> levels following <z:chebi fb="105" ids="17234">glucose</z:chebi>/oxygen deprivation, as well as augmented cytosolic <z:chebi fb="0" ids="29108">Ca2+</z:chebi> levels in nerve terminals following depolarization in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, major increases in <z:mpath ids='MPATH_124'>infarct</z:mpath> size are seen in gelsolin-null mice after reversible middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, compared with controls </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, treatment with <z:chebi fb="0" ids="23528">cytochalasin</z:chebi> D, a fungal toxin that depolymerizes actin filaments, reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size of both gelsolin-null and control mice to the same final volume </plain></SENT>
<SENT sid="5" pm="."><plain>Hence, enhancement or mimicry of gelsolin activity may be neuroprotective during <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>